Laboratory analysis

Laboratory analysis is the testing of a substance sample by an analytical laboratory to establish what it contains and in what proportions. It addresses a fundamental gap in drug checking: reagent tests and fentanyl test strips can indicate the probable presence or absence of particular compound classes, but they cannot confirm identity or detect everything that may be present.

The most common analytical techniques are gas chromatography–mass spectrometry (GC-MS) and liquid chromatography–mass spectrometry (LC-MS). Both separate a sample's components and identify each by its molecular signature. Some services also report quantitative results — the relative proportion of each compound — though identification alone is more common in drug-checking contexts.

Access varies sharply. Some harm-reduction organisations operate on-site instruments; elsewhere the only route is a postal drug-checking service or a private commercial laboratory. In most places where samples are actually taken, laboratory analysis is not immediately available.

How it is done

A small portion of the sample is dissolved in solvent and submitted to the instrument. The chromatograph separates the mixture's components over time; the mass spectrometer identifies each by fragmenting it and comparing the resulting pattern to a reference library. The laboratory then reports what it found, in what approximate proportions, and how confident it is in each identification.

Portable instruments — including handheld mass spectrometers and FTIR (Fourier-transform infrared) devices — can return results on-site in minutes, though their reference libraries are narrower than those of full laboratory setups. Postal services typically take days to weeks. Most services require only a small amount of material: residue from packaging or a fragment of a tablet is often sufficient, and some operate anonymously.

What it cannot tell you

A laboratory result identifies what was present in the portion of the sample tested. It does not establish that the rest of the batch matches. Powders and pressed tablets can be unevenly mixed, so a tested portion may not represent the next gram or the next pill from the same supply. This is most acute with pressed tablets, where active compounds can be distributed unevenly across the material.

Laboratory analysis also does not establish what a confirmed composition will do to a particular person. A result naming two or three compounds describes what is there; it says nothing about their combined effect, individual tolerance, or interactions with medications or health conditions. The most consequential wrong conclusion from a clean laboratory result is that the sample is therefore safe — the result confirms identity, not safety.

Finally, laboratory analysis is bounded by its reference library. Novel psychoactive substances or structural analogues not yet catalogued may be detected as an unknown compound, misidentified as a known one, or flagged with low confidence. A result that returns without a confident match should be treated as an unknown, not as a negative.